Lack of association between human immunodeficiency virus type 1 antibody in cervicovaginal lavage fluid and plasma and perinatal transmission, in Thailand

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 1957-1963

  Chuachoowong, Rutt ^a,d,i   Shaffer, Nathan ^d,e   VanCott, Thomas C ^f   Chaisilwattana, Pongsakdi ^a   Siriwasin, Wimol ^b   Waranawat, Naris ^c   Vanprapar, Nirun ^a   Young, Nancy L ^d,e   Mastro, Timothy D ^d,e   Lambert, John S ^h   Robb, Merlin L ^g  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

^c Queen Sirikit National Institute for Child Health   (Thailand)

^d HIV/AIDS Collaboration   (Thailand)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^g WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 160; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS RNA; ZIDOVUDINE;

ANTIBODY TITER; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAVAGE; MAJOR CLINICAL STUDY; PERINATAL INFECTION; PRIORITY JOURNAL; THAILAND; UTERINE CERVIX; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CERVIX UTERI; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP160; HIV-1; HUMANS; IRRIGATION; PREGNANCY; RNA, VIRAL; VAGINA; ZIDOVUDINE;

EID: 0034049841     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315499     Document Type: Article

References (24)

1. 1. Newell ML. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS 1998; 12:831-7.
2. 2. Mock PA, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. AIDS 1999: 13:407-14.
3. 3. Bryson YJ. Perinatal HIV-1 transmission: recent advances and therapeutic interventions. AIDS 1996; 10(Suppl 3):S33-42.
4. 4. Shaffer N, Chuachoowong R, Mock PA, et al. Randomized placebo-controlled trial of short-course antenatal zidovudine to reduce perinatal HIV transmission. Bangkok, Thailand. Lancet 1999; 353:773-80.
5. 5. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996; 335:1621-9.
6. 6. Chuachoowong R, Shaffer N, Siriwasin W, et al. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. J Infect Dis 2000; 181:99-106.
7. 7. Shaffer N, Roongpisuthipong A, Siriwasin W, et al. Maternal viral load and perinatal HIV-1 subtype E transmission, Thailand. J Infect Dis 1999; 179: 590-9.
8. 8. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999; 341:385-93.
9. 9. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999; 341:394-402.
10. 10. Murphy BR. Mucosal immunity to viruses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunology. 1st ed. San Diego: Academic Press, 1994:333-43.
11. 11. Cohen MS, Anderson DJ. Genitourinary mucosal defenses. In: Holmes KK. Märdh PA, Sparling PF, et al, eds. Sexually transmitted diseases. 3d ed. New York: McGraw-Hill, 1999:173-90.
12. 12. Haimovici F, Nayer KH, Anderson DJ. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15:185-91.
13. 13. Belec L, Gresenguet G, Dragon M, Meillet D, Pillot J. Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: application to detection of seminal antibodies after sexual intercourse. J Clin Microbiol 1994; 32:1249-55.
14. 14. Lu XS, Belec L, Pillot J. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis 1993; 167: 1189-92.
15. 15. Belec L, Dupre T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) with normal or impaired IgA local response in HIV infection. J Infect Dis 1995; 172:691-7.
16. 16. Yolken R, Miotti P, Dallabetta G, Chiphangwi J, Clayman B, Viscidi R. Secretory immune response to HIV and perinatal transmission [abstract]. Pediatr Res 1993; 33:189A.
17. 17. Nielson K, Boyer P, Dillon M, et al. Presence of human immunodeficiency virus (HIV) type 1 and HIV-1 specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infants. J Infect Dis 1996; 173:1001-4.
18. 18. Artenstein AW, VanCott TC, Sitz KV, et al. Mucosal immune responses in four distinct components of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis 1997; 175:265-71.
19. 19. National Institute of Allergy and Infectious Diseases, Division of AIDS. DAIDS virology manual for laboratories. Washington, DC: US Department of Health and Human Services, 1997; publication no. NIH-97-3828.
20. 20. Beyrer C, Artenstein AW, Rugpao S, et al. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999; 179:59-67.
21. 21. Mazzoli S, Trabattoni D, Caputo SL, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997; 3:1250-7.
22. 22. Belec L, Georges AJ, Steenman G, Martin PM. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989; 160:385-91.
23. 23. Parr MB, Parr EL. Mucosal immunity in the female and male reproductive tracts. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of mucosal immunity. 1st ed. San Diego: Academic Press, 1994:677-89.
24. 24. Robb ML, Ketsararat W. Sriplienchan S, et al. Neutralizing antibody, plasma and cervical viral burden in relation to maternal-infant transmission in northern Thailand [abstract 23290]. In: Conference record of the 12th World AIDS Conference (Geneva). Geneva: Marathon Multimedia, 1998.